ALS2_HUMAN - dbPTM
ALS2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ALS2_HUMAN
UniProt AC Q96Q42
Protein Name Alsin
Gene Name ALS2
Organism Homo sapiens (Human).
Sequence Length 1657
Subcellular Localization
Protein Description May act as a GTPase regulator. Controls survival and growth of spinal motoneurons (By similarity)..
Protein Sequence MDSKKRSSTEAEGSKERGLVHIWQAGSFPITPERLPGWGGKTVLQAALGVKHGVLLTEDGEVYSFGTLPWRSGPVEICPSSPILENALVGQYVITVATGSFHSGAVTDNGVAYMWGENSAGQCAVANQQYVPEPNPVSIADSEASPLLAVRILQLACGEEHTLALSISREIWAWGTGCQLGLITTAFPVTKPQKVEHLAGRVVLQVACGAFHSLALVQCLPSQDLKPVPERCNQCSQLLITMTDKEDHVIISDSHCCPLGVTLTESQAENHASTALSPSTETLDRQEEVFENTLVANDQSVATELNAVSAQITSSDAMSSQQNVMGTTEISSARNIPSYPDTQAVNEYLRKLSDHSVREDSEHGEKPVPSQPLLEEAIPNLHSPPTTSTSALNSLVVSCASAVGVRVAATYEAGALSLKKVMNFYSTTPCETGAQAGSSAIGPEGLKDSREEQVKQESMQGKKSSSLVDIREEETEGGSRRLSLPGLLSQVSPRLLRKAARVKTRTVVLTPTYSGEADALLPSLRTEVWTWGKGKEGQLGHGDVLPRLQPLCVKCLDGKEVIHLEAGGYHSLALTAKSQVYSWGSNTFGQLGHSDFPTTVPRLAKISSENGVWSIAAGRDYSLFLVDTEDFQPGLYYSGRQDPTEGDNLPENHSGSKTPVLLSCSKLGYISRVTAGKDSYLALVDKNIMGYIASLHELATTERRFYSKLSDIKSQILRPLLSLENLGTTTTVQLLQEVASRFSKLCYLIGQHGASLSSFLHGVKEARSLVILKHSSLFLDSYTEYCTSITNFLVMGGFQLLAKPAIDFLNKNQELLQDLSEVNDENTQLMEILNTLFFLPIRRLHNYAKVLLKLATCFEVASPEYQKLQDSSSCYECLALHLGRKRKEAEYTLGFWKTFPGKMTDSLRKPERRLLCESSNRALSLQHAGRFSVNWFILFNDALVHAQFSTHHVFPLATLWAEPLSEEAGGVNGLKITTPEEQFTLISSTPQEKTKWLRAISQAVDQALRGMSDLPPYGSGSSVQRQEPPISRSAKYTFYKDPRLKDATYDGRWLSGKPHGRGVLKWPDGKMYSGMFRNGLEDGYGEYRIPNKAMNKEDHYVGHWKEGKMCGQGVYSYASGEVFEGCFQDNMRHGHGLLRSGKLTSSSPSMFIGQWVMDKKAGYGVFDDITRGEKYMGMWQDDVCQGNGVVVTQFGLYYEGNFHLNKMMGNGVLLSEDDTIYEGEFSDDWTLSGKGTLTMPNGDYIEGYFSGEWGSGIKITGTYFKPSLYESDKDRPKVFRKLGNLAVPADEKWKAVFDECWRQLGCEGPGQGEVWKAWDNIAVALTTSRRQHRDSPEILSRSQTQTLESLEFIPQHVGAFSVEKYDDIRKYLIKACDTPLHPLGRLVETLVAVYRMTYVGVGANRRLLQEAVKEIKSYLKRIFQLVRFLFPELPEEGSTIPLSAPLPTERKSFCTGKSDSRSESPEPGYVVTSSGLLLPVLLPRLYPPLFMLYALDNDREEDIYWECVLRLNKQPDIALLGFLGVQRKFWPATLSILGESKKVLPTTKDACFASAVECLQQISTTFTPSDKLKVIQQTFEEISQSVLASLHEDFLWSMDDLFPVFLYVVLRARIRNLGSEVHLIEDLMDPYLQHGEQGIMFTTLKACYYQIQREKLN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9PhosphorylationDSKKRSSTEAEGSKE
CCCCCCCCCCCCCCC
40.2228985074
31PhosphorylationQAGSFPITPERLPGW
ECCCCCCCCCCCCCC
21.2346162777
41UbiquitinationRLPGWGGKTVLQAAL
CCCCCCHHHHHHHHH
31.36-
166PhosphorylationEEHTLALSISREIWA
CCCEEHHEEEHHHHH
16.9524719451
353PhosphorylationNEYLRKLSDHSVRED
HHHHHHHCCCCCCCC
35.9926657352
356PhosphorylationLRKLSDHSVREDSEH
HHHHCCCCCCCCCCC
28.0629449344
361PhosphorylationDHSVREDSEHGEKPV
CCCCCCCCCCCCCCC
27.0969013021
417PhosphorylationTYEAGALSLKKVMNF
EEECCCCCHHHHHCC
37.2924719451
425PhosphorylationLKKVMNFYSTTPCET
HHHHHCCCCCCCCCC
10.4923879269
426PhosphorylationKKVMNFYSTTPCETG
HHHHCCCCCCCCCCC
22.9723879269
464PhosphorylationESMQGKKSSSLVDIR
HHHCCCCCCCCEECC
28.7530266825
465PhosphorylationSMQGKKSSSLVDIRE
HHCCCCCCCCEECCH
36.2530266825
466PhosphorylationMQGKKSSSLVDIREE
HCCCCCCCCEECCHH
39.2319664994
475PhosphorylationVDIREEETEGGSRRL
EECCHHHCCCCCCCC
43.1223403867
479PhosphorylationEEETEGGSRRLSLPG
HHHCCCCCCCCCHHH
25.6923403867
481MethylationETEGGSRRLSLPGLL
HCCCCCCCCCHHHHH
30.26-
483PhosphorylationEGGSRRLSLPGLLSQ
CCCCCCCCHHHHHHH
30.6119664994
489PhosphorylationLSLPGLLSQVSPRLL
CCHHHHHHHCCHHHH
33.3130266825
492PhosphorylationPGLLSQVSPRLLRKA
HHHHHHCCHHHHHHH
9.1819664994
506PhosphorylationAARVKTRTVVLTPTY
HCCCCCCEEEECCCC
21.8725850435
510PhosphorylationKTRTVVLTPTYSGEA
CCCEEEECCCCCCCH
11.2825850435
512PhosphorylationRTVVLTPTYSGEADA
CEEEECCCCCCCHHH
25.6925850435
513PhosphorylationTVVLTPTYSGEADAL
EEEECCCCCCCHHHH
18.8425954137
514PhosphorylationVVLTPTYSGEADALL
EEECCCCCCCHHHHC
32.4125850435
523PhosphorylationEADALLPSLRTEVWT
CHHHHCHHHEEEEEE
30.3824719451
526PhosphorylationALLPSLRTEVWTWGK
HHCHHHEEEEEEECC
39.9446162783
530PhosphorylationSLRTEVWTWGKGKEG
HHEEEEEEECCCCCC
29.5246162789
533MalonylationTEVWTWGKGKEGQLG
EEEEEECCCCCCCCC
59.3726320211
533AcetylationTEVWTWGKGKEGQLG
EEEEEECCCCCCCCC
59.3719608861
644PhosphorylationYSGRQDPTEGDNLPE
ECCCCCCCCCCCCCC
61.9722210691
656PhosphorylationLPENHSGSKTPVLLS
CCCCCCCCCCCEEEE
36.0522210691
658PhosphorylationENHSGSKTPVLLSCS
CCCCCCCCCEEEEEC
21.9622210691
677UbiquitinationISRVTAGKDSYLALV
EEEEECCCCCEEEEE
40.83-
714PhosphorylationSKLSDIKSQILRPLL
HHHHHHHHHHHHHHH
23.8446162771
849 (in isoform 1)Ubiquitination-24.0521890473
849UbiquitinationRRLHNYAKVLLKLAT
HHHHHHHHHHHHHHH
24.0521890473
849UbiquitinationRRLHNYAKVLLKLAT
HHHHHHHHHHHHHHH
24.0521890473
906PhosphorylationFPGKMTDSLRKPERR
CCCCCCCCCCCHHHH
22.4026091039
993UbiquitinationISSTPQEKTKWLRAI
ECCCHHHHHHHHHHH
50.59-
1036PhosphorylationPISRSAKYTFYKDPR
CCCCCCCEEEECCCC
11.2028152594
1037PhosphorylationISRSAKYTFYKDPRL
CCCCCCEEEECCCCC
21.5628152594
1039PhosphorylationRSAKYTFYKDPRLKD
CCCCEEEECCCCCCC
13.4928152594
1055PhosphorylationTYDGRWLSGKPHGRG
EECCCCCCCCCCCCC
37.50108417795
1057UbiquitinationDGRWLSGKPHGRGVL
CCCCCCCCCCCCCCE
30.39-
1084PhosphorylationRNGLEDGYGEYRIPN
CCCCCCCCCCCCCCC
21.077067023
1144PhosphorylationLLRSGKLTSSSPSMF
CCCCCCCCCCCCCCC
30.0127251275
1145PhosphorylationLRSGKLTSSSPSMFI
CCCCCCCCCCCCCCC
38.9828348404
1146PhosphorylationRSGKLTSSSPSMFIG
CCCCCCCCCCCCCCE
40.8228348404
1147PhosphorylationSGKLTSSSPSMFIGQ
CCCCCCCCCCCCCEE
22.2924719451
1149PhosphorylationKLTSSSPSMFIGQWV
CCCCCCCCCCCEEEH
28.4228348404
1160UbiquitinationGQWVMDKKAGYGVFD
EEEHHCCCCCCCCCC
42.66-
1281AcetylationDRPKVFRKLGNLAVP
CCCHHHHHHCCCCCC
49.6420167786
1292AcetylationLAVPADEKWKAVFDE
CCCCCCHHHHHHHHH
55.327696719
1335PhosphorylationSRRQHRDSPEILSRS
CCCCCCCCHHHHCCH
25.1223401153
1340PhosphorylationRDSPEILSRSQTQTL
CCCHHHHCCHHCCCH
35.2323403867
1342PhosphorylationSPEILSRSQTQTLES
CHHHHCCHHCCCHHH
33.9228857561
1344PhosphorylationEILSRSQTQTLESLE
HHHCCHHCCCHHHHC
25.4317525332
1346PhosphorylationLSRSQTQTLESLEFI
HCCHHCCCHHHHCCC
35.5627251275
1349PhosphorylationSQTQTLESLEFIPQH
HHCCCHHHHCCCHHH
35.99113332709
1394PhosphorylationVETLVAVYRMTYVGV
HHHHHHHHHHHHCCC
5.7322817900
1398PhosphorylationVAVYRMTYVGVGANR
HHHHHHHHCCCCHHH
5.9522817900
1417PhosphorylationEAVKEIKSYLKRIFQ
HHHHHHHHHHHHHHH
41.1628851738
1452PhosphorylationPLPTERKSFCTGKSD
CCCCCCCCCCCCCCC
31.6024719451
1458PhosphorylationKSFCTGKSDSRSESP
CCCCCCCCCCCCCCC
42.0122115753
1460PhosphorylationFCTGKSDSRSESPEP
CCCCCCCCCCCCCCC
44.8130278072
1462PhosphorylationTGKSDSRSESPEPGY
CCCCCCCCCCCCCCE
46.5122167270
1464PhosphorylationKSDSRSESPEPGYVV
CCCCCCCCCCCCEEE
35.4922167270
1469PhosphorylationSESPEPGYVVTSSGL
CCCCCCCEEEECCCC
11.4922167270
1472PhosphorylationPEPGYVVTSSGLLLP
CCCCEEEECCCCCHH
13.7128176443
1473PhosphorylationEPGYVVTSSGLLLPV
CCCEEEECCCCCHHH
15.7028176443
1474PhosphorylationPGYVVTSSGLLLPVL
CCEEEECCCCCHHHH
24.8828176443

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ALS2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ALS2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ALS2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NEK1_HUMANNEK1physical
28514442
CU002_HUMANC21orf2physical
28514442
RBM6_HUMANRBM6physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
205100Amyotrophic lateral sclerosis 2 (ALS2)
606353Juvenile primary lateral sclerosis (JPLS)
607225Infantile-onset ascending spastic paralysis (IAHSP)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ALS2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-533, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483 AND SER-492, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1464, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483 AND SER-492, ANDMASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483 AND SER-492, ANDMASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1464, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1344, AND MASSSPECTROMETRY.

TOP